$2.99 Billion is the total value of Redmile Group, LLC's 74 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALLK | Buy | ALLAKOS INC | $241,955,000 | +142.8% | 3,077,128 | +33.8% | 8.10% | +187.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $182,777,000 | -35.7% | 22,790,134 | -0.0% | 6.12% | -24.0% |
| FATE | Buy | FATE THERAPEUTICS INC | $174,197,000 | -17.2% | 11,216,809 | +8.3% | 5.83% | -2.1% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $162,264,000 | +223.6% | 4,780,898 | +115.0% | 5.43% | +282.7% |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $155,499,000 | +60.2% | 8,244,896 | 0.0% | 5.20% | +89.5% | |
| ARGX | Buy | ARGENX SEsponsored adr | $123,126,000 | -18.6% | 1,080,432 | +1.1% | 4.12% | -3.8% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $114,229,000 | +50.9% | 2,252,600 | +34.9% | 3.82% | +78.5% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $113,826,000 | – | 1,162,200 | +100.0% | 3.81% | – |
| QURE | Buy | UNIQURE NV | $94,863,000 | -27.3% | 2,410,125 | +44.4% | 3.18% | -14.0% |
| EPZM | Sell | EPIZYME INC | $89,090,000 | -18.7% | 8,636,933 | -1.1% | 2.98% | -3.8% |
| RGNX | Buy | REGENXBIO INC | $84,105,000 | +17.7% | 2,362,486 | +69.8% | 2.82% | +39.1% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $83,221,000 | -26.0% | 2,962,655 | -0.3% | 2.78% | -12.5% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $68,440,000 | -9.0% | 1,160,401 | -0.5% | 2.29% | +7.6% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $65,239,000 | -8.1% | 3,177,760 | +16.8% | 2.18% | +8.7% |
| TCDA | Buy | TRICIDA INC | $64,139,000 | -16.4% | 2,077,700 | +6.8% | 2.15% | -1.2% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $63,818,000 | -31.0% | 4,519,717 | -1.8% | 2.14% | -18.4% |
| CELG | Buy | CELGENE CORP | $55,876,000 | +8.5% | 562,700 | +1.0% | 1.87% | +28.3% |
| IGMS | New | IGM BIOSCIENCES INC | $55,806,000 | – | 3,144,000 | +100.0% | 1.87% | – |
| NVRO | Buy | NEVRO CORP | $55,353,000 | +25060.5% | 643,864 | +18837.2% | 1.85% | +30766.7% |
| WMGI | Buy | WRIGHT MED GROUP N V | $49,598,000 | -29.9% | 2,404,157 | +1.3% | 1.66% | -17.1% |
| DXCM | Buy | DEXCOM INC | $45,393,000 | +76.0% | 304,158 | +76.7% | 1.52% | +108.1% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $40,365,000 | +20.4% | 3,888,752 | +7.4% | 1.35% | +42.4% |
| PEN | New | PENUMBRA INC | $40,074,000 | – | 297,972 | +100.0% | 1.34% | – |
| PRAH | New | PRA HEALTH SCIENCES INC | $39,236,000 | – | 395,400 | +100.0% | 1.31% | – |
| KRYS | Sell | KRYSTAL BIOTECH INC | $37,444,000 | -13.9% | 1,078,300 | -0.2% | 1.25% | +1.8% |
| IMGN | Buy | IMMUNOGEN INC | $35,372,000 | +16.8% | 14,616,560 | +4.7% | 1.18% | +38.2% |
| CNC | Buy | CENTENE CORP DEL | $35,062,000 | -3.2% | 810,498 | +17.3% | 1.17% | +14.4% |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $33,200,000 | +21.6% | 923,003 | +5.1% | 1.11% | +43.7% |
| REPL | Buy | REPLIMUNE GROUP INC | $30,766,000 | -4.5% | 2,213,417 | +0.7% | 1.03% | +13.1% |
| XNCR | Sell | XENCOR INC | $29,670,000 | -55.1% | 879,627 | -45.5% | 0.99% | -46.8% |
| XERS | XERIS PHARMACEUTICALS INC | $29,496,000 | -14.1% | 3,000,641 | 0.0% | 0.99% | +1.6% | |
| HCA | New | HCA HEALTHCARE INC | $28,359,000 | – | 235,500 | +100.0% | 0.95% | – |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $27,697,000 | +19.4% | 25,000,000 | 0.0% | 0.93% | +41.3% | ||
| TCRR | Sell | TCR2 THERAPEUTICS INC | $26,908,000 | +4.5% | 1,790,288 | -0.5% | 0.90% | +23.5% |
| GRTS | Sell | GRITSTONE ONCOLOGY INC | $26,807,000 | -25.2% | 3,104,494 | -3.5% | 0.90% | -11.5% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $26,490,000 | +18.3% | 1,164,402 | -0.4% | 0.89% | +40.0% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $25,574,000 | -44.8% | 2,857,389 | -2.2% | 0.86% | -34.7% |
| GMAB | New | GENMAB A Ssponsored ads | $25,297,000 | – | 1,248,600 | +100.0% | 0.85% | – |
| LIVN | Sell | LIVANOVA PLC | $25,309,000 | -17.0% | 342,987 | -19.1% | 0.85% | -1.9% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $24,039,000 | +0.1% | 187,599 | +11.4% | 0.80% | +18.4% |
| PRNB | Buy | PRINCIPIA BIOPHARMA INC | $22,310,000 | +175.4% | 790,006 | +223.6% | 0.75% | +226.2% |
| STOK | Sell | STOKE THERAPEUTICS INC | $21,866,000 | -26.6% | 1,017,478 | -0.4% | 0.73% | -13.2% |
| AXNX | Sell | AXONICS MODULATION TECH INC | $21,797,000 | -34.6% | 809,700 | -0.5% | 0.73% | -22.7% |
| ANAB | Buy | ANAPTYSBIO INC | $21,433,000 | -37.7% | 612,558 | +0.5% | 0.72% | -26.3% |
| ODT | Buy | ODONATE THERAPEUTICS INC | $20,136,000 | -25.9% | 773,571 | +4.4% | 0.67% | -12.4% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $15,953,000 | -29.0% | 3,115,865 | -0.7% | 0.53% | -16.0% |
| HOOK | Buy | HOOKIPA PHARMA INC | $14,233,000 | +11.8% | 1,897,721 | +0.3% | 0.48% | +32.2% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $14,179,000 | -72.5% | 3,607,800 | +4.2% | 0.47% | -67.5% |
| BCEL | Sell | ATRECA INC | $13,943,000 | -35.1% | 1,139,106 | -0.1% | 0.47% | -23.2% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $13,102,000 | -36.2% | 424,000 | -0.2% | 0.44% | -24.6% |
| STXS | New | STEREOTAXIS INC | $11,530,000 | – | 3,285,000 | +100.0% | 0.39% | – |
| FTSV | Buy | FORTY SEVEN INC | $10,449,000 | +321.3% | 1,627,498 | +595.5% | 0.35% | +400.0% |
| VAPO | VAPOTHERM INC | $9,087,000 | -58.8% | 959,539 | 0.0% | 0.30% | -51.3% | |
| GTHX | Buy | G1 THERAPEUTICS INC | $8,905,000 | -0.8% | 390,934 | +33.5% | 0.30% | +17.3% |
| GLYC | Sell | GLYCOMIMETICS INC | $8,610,000 | -64.0% | 1,997,647 | -0.5% | 0.29% | -57.5% |
| LOGC | Sell | LOGICBIO THERAPEUTICS INC | $8,097,000 | -23.6% | 749,026 | -8.1% | 0.27% | -9.7% |
| CMRX | Sell | CHIMERIX INC | $7,604,000 | -50.5% | 3,235,795 | -9.1% | 0.25% | -41.6% |
| SDC | New | SMILEDIRECTCLUB INC | $6,806,000 | – | 490,340 | +100.0% | 0.23% | – |
| GOSS | Buy | GOSSAMER BIO INC | $4,374,000 | -20.7% | 260,500 | +4.8% | 0.15% | -6.4% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $400,000 | +46.0% | 14,700 | +28.9% | 0.01% | +62.5% |
| MYOK | Buy | MYOKARDIA INC | $375,000 | +19.8% | 7,182 | +14.9% | 0.01% | +44.4% |
| OVID | Sell | OVID THERAPEUTICS INC | $395,000 | -71.0% | 121,950 | -83.5% | 0.01% | -66.7% |
| AMED | AMEDISYS INC | $304,000 | +7.8% | 2,320 | 0.0% | 0.01% | +25.0% | |
| FLXN | FLEXION THERAPEUTICS INC | $296,000 | +11.3% | 21,630 | 0.0% | 0.01% | +25.0% | |
| ELGXQ | ENDOLOGIX INC | $313,000 | -45.1% | 78,755 | 0.0% | 0.01% | -37.5% | |
| INSP | New | INSPIRE MED SYS INC | $239,000 | – | 3,910 | +100.0% | 0.01% | – |
| LHCG | LHC GROUP INC | $246,000 | -5.0% | 2,166 | 0.0% | 0.01% | +14.3% | |
| VCEL | VERICEL CORP | $253,000 | -19.9% | 16,720 | 0.0% | 0.01% | -11.1% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $247,000 | +6.9% | 2,740 | 0.0% | 0.01% | +14.3% | |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $215,000 | – | 75,000 | +100.0% | 0.01% | – |
| UNH | Sell | UNITEDHEALTH GROUP INC | $211,000 | -99.4% | 971 | -99.3% | 0.01% | -99.3% |
| ESTA | ESTABLISHMENT LABS HLDGS INC | $189,000 | -14.1% | 10,000 | 0.0% | 0.01% | 0.0% | |
| VKTX | VIKING THERAPEUTICS INC | $112,000 | -17.0% | 16,260 | 0.0% | 0.00% | 0.0% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $14,000 | -57.6% | 10,229 | 0.0% | 0.00% | -100.0% | |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -22,236 | -100.0% | -0.01% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -254,590 | -100.0% | -0.04% | – |
| AVDR | Exit | AVEDRO INC | $0 | – | -216,200 | -100.0% | -0.12% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -39,900 | -100.0% | -0.14% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -97,191 | -100.0% | -0.24% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -100,000 | -100.0% | -0.24% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -375,375 | -100.0% | -0.25% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -188,000 | -100.0% | -0.28% | – |
| PSNL | Exit | PERSONALIS INC | $0 | – | -400,000 | -100.0% | -0.31% | – |
| MOR | Exit | MORPHOSYS AGsponsored ads | $0 | – | -733,699 | -100.0% | -0.50% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -1,796,477 | -100.0% | -0.70% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -461,880 | -100.0% | -0.87% | – |
| Exit | ARRAY BIOPHARMA INCnote 2.625%12/0 | $0 | – | -16,500,000 | -100.0% | -1.42% | – | |
| ANTM | Exit | ANTHEM INC | $0 | – | -183,500 | -100.0% | -1.46% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -412,000 | -100.0% | -1.77% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -888,705 | -100.0% | -2.16% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -8,752,254 | -100.0% | -11.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.